A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/X...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/X...